Literature DB >> 10975608

Variations of the bilirubin uridine-diphosphoglucuronosyl transferase 1A1 gene in healthy Taiwanese.

C S Huang1, G A Luo, M L Huang, S C Yu, S S Yang.   

Abstract

The activity of uridine-diphosphoglucuronosyl transferase 1 (UGT1) may influence the concentration of serum bilirubin. Because UGT1 is too labile to be measured with classical biochemical methods, we analysed the whole UGT1A1 gene in 290 healthy Taiwanese adults by using the polymerase chain reaction method, and investigated the relationship between UGT1A1 genotypes and serum bilirubin levels. The results showed that slightly more than 50% of the subjects had one or more variant sites in UGT1A1 gene. The most common variant was A(TA)6TAA/A(TA)7TAA (6/7) in the promoter area, followed by heterozygous variation within the coding region, compound heterozygous and homozygous variations. Among the four variant sites within the coding region, 211 G to A was the predominate one, 1091 C to T was a novel variation, and 686 C to A was associated with 6/7. Subjects with 6/7 or heterozygous variation within the coding region or compound heterozygous (plus one homozygous) variation had significantly higher bilirubin levels than those with wild UGT1A1 gene. When the 290 subjects were stratified into six groups according to their serum bilirubin concentrations, the bilirubin levels were correlated well to the frequencies of variant UGT1A1 gene. Our results show that there is a strong association between UGT1A1 gene and bilirubin levels in healthy Taiwanese adults. The occurrence of A(TA)7TAA allele was relatively rare and the variation rate within the coding region was much higher in Taiwanese compared to that in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975608     DOI: 10.1097/00008571-200008000-00007

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  26 in total

Review 1.  The role of pharmacogenetics in cancer therapeutics.

Authors:  Wei Peng Yong; Federico Innocenti; Mark J Ratain
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

2.  Is there diversity among UGT1A1 polymorphism in Japan?

Authors:  Michiya Kobayashi; Shoichi Hazama; Kenichi Takahashi; Koji Oba; Naoko Okayama; Mitsuaki Nishioka; Yuji Hinoda; Masaaki Oka; Ken Okamoto; Hiromichi Maeda; Daisuke Nakamura; Junichi Sakamoto; Hideyuki Mishima
Journal:  World J Gastrointest Oncol       Date:  2012-07-15

3.  Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Authors:  Douglas S Hawkins; Yueh-Yun Chi; James R Anderson; Jing Tian; Carola A S Arndt; Lisa Bomgaars; Sarah S Donaldson; Andrea Hayes-Jordan; Leo Mascarenhas; Mary Beth McCarville; Jeannine S McCune; Geoff McCowage; Lynn Million; Carol D Morris; David M Parham; David A Rodeberg; Erin R Rudzinski; Margarett Shnorhavorian; Sheri L Spunt; Stephen X Skapek; Lisa A Teot; Suzanne Wolden; Torunn I Yock; William H Meyer
Journal:  J Clin Oncol       Date:  2018-08-09       Impact factor: 44.544

Review 4.  Pharmacogenetics: a tool for individualizing antineoplastic therapy.

Authors:  F Innocenti; L Iyer; M J Ratain
Journal:  Clin Pharmacokinet       Date:  2000-11       Impact factor: 6.447

5.  Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.

Authors:  T M Bosch; V D Doodeman; P H M Smits; I Meijerman; J H M Schellens; J H Beijnen
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

6.  Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes.

Authors:  Kung-Sheng Tang; Hui-Fen Chiu; Hong-Hwa Chen; Hock-Liew Eng; Chia-Jung Tsai; Hsiu-Chen Teng; Ching-Shan Huang
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

7.  Pharmacogenetics of irinotecan: An ethnicity-based prediction of irinotecan adverse events.

Authors:  Shouji Shimoyama
Journal:  World J Gastrointest Surg       Date:  2010-01-27

Review 8.  Systemic therapies for pancreatic cancer--the role of pharmacogenetics.

Authors:  Ross A Soo; Wei-Peng Yong; Federico Innocenti
Journal:  Curr Drug Targets       Date:  2012-06       Impact factor: 3.465

9.  Polymorphisms of uridine-diphosphoglucuronosyltransferase 1A7 gene in Taiwan Chinese.

Authors:  May-Jen Huang; Sien-Sing Yang; Min-Shung Lin; Ching-Shan Huang
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

10.  Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genes.

Authors:  Yuan Ming Di; Eli Chan; Ming Qian Wei; Jun-Ping Liu; Shu-Feng Zhou
Journal:  AAPS J       Date:  2009-07-02       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.